Clinical implication of residual MIBG‐positive disease in the follow‐up of high‐risk neuroblastoma treated with tandem high‐dose chemotherapy and autologous stem cell transplantation-Reference-Cited by-同舟云学术

Clinical implication of residual MIBG‐positive disease in the follow‐up of high‐risk neuroblastoma treated with tandem high‐dose chemotherapy and autologous stem cell transplantation

Published:2021-12-10 Issue: Volume: Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Seo Eun Seop¹,Shin Muheon²,Lim Hana¹,Cho Hee Won¹,Ju Hee Young¹,Cho Young‐Seok²,Yoo Keon Hee¹,Koo Hong Hoe¹,Lee Ji Won¹,Sung Ki Woong¹^ORCID

Affiliation:

1. Department of Pediatrics, Samsung Medical Center Sungkyunkwan University School of Medicine Seoul Republic of Korea

2. Department of Nuclear Medicine, Samsung Medical Center Sungkyunkwan University School of Medicine Seoul Republic of Korea

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29502

Reference24 articles.

1. Iodine-123 Metaiodobenzylguanidine Scintigraphy Scoring Allows Prediction of Outcome in Patients With Stage 4 Neuroblastoma: Results of the Cologne Interscore Comparison Study

2. Scintigraphic Response by 123I-Metaiodobenzylguanidine Scan Correlates With Event-Free Survival in High-Risk Neuroblastoma

3. Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology Group

4. Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children’s Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1

5. Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances and Challenges in Cancer Stem Cells for Onco-Therapeutics;Stem Cells International;2023-12-06

2. A narrative review of radiomics and deep learning advances in neuroblastoma: updates and challenges;Pediatric Radiology;2023-11-10

3. Therapy resistance in neuroblastoma: Mechanisms and reversal strategies;Frontiers in Pharmacology;2023-02-16

4. Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants;Cancers;2022-09-20

5. Postchemotherapy gross residual tumor in non‐high‐risk neuroblastoma: Clinical significance and the role of adjuvant therapy;Pediatric Blood & Cancer;2022-06-23